Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
37 studies found for:    "Raynaud Disease"
Show Display Options
Rank Status Study
1 Completed Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Condition: Raynaud's Disease
Intervention: Drug: SLx-2101
2 Completed Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Raynaud's Disease Secondary to Scleroderma;   Raynaud's Disease Secondary to Autoimmune Disease
Intervention: Drug: MQX-503
3 Unknown  A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
Conditions: Raynaud's Disease;   Raynaud's Disease Secondary to Scleroderma;   Raynaud's Disease Secondary to Other Autoimmune Disease
Interventions: Drug: Nitroglycerin;   Drug: Topical AmphiMatrix
4 Completed Lab Study of MQX-503 in Treatment of Raynaud's
Conditions: Raynaud Disease;   Raynaud Disease Secondary to Scleroderma;   Raynaud Secondary to Other Autoimmune Disease
Intervention: Drug: topical organogel with nitroglycerin
5 Completed Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Topical organogel with nitroglycerin
6 Completed Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Nitroglycerin
7 Completed Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
Condition: Raynaud Disease
Intervention: Drug: Tadalafil
8 Active, not recruiting A Two-Part Study of BOTOX® Therapy for Ischemic Digits
Condition: Raynaud's Disease
Intervention: Drug: onabotulinum toxin type-A
9 Unknown  Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Condition: Raynaud Disease
Intervention: Drug: Ginkgo biloba extract EGb 761®
10 Unknown  Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
Condition: Raynaud Disease
Interventions: Drug: 0.9% nitroglycerin in TAM cream;   Drug: vehicle cream
11 Recruiting Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
Conditions: Raynaud Disease;   Scleroderma, Systemic
Interventions: Procedure: laser speckle contrast imaging;   Procedure: Cooling
12 Recruiting Epoxy-eicosatrienoic Acid and Nitrogen Monoxide in Post-occlusive Cutaneous Finger Hyperaemia and the Response to Cold in Primary Raynaud Phenomenon.
Conditions: Raynaud Disease;   Hyperemia;   Cold;   Fluconazole
Interventions: Procedure: post-occlusive hyperemia;   Procedure: cooling box;   Drug: L-NMMA and Fluconazole dermic injection
13 Completed Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Condition: Raynaud Disease
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
14 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
Conditions: Systemic Sclerosis;   Raynaud Disease
Intervention: Drug: iloprost
15 Active, not recruiting Metabolomic Analysis of Systemic Sclerosis
Conditions: Scleroderma (Limited and Diffuse);   Undifferentiated Connective Tissue Disease;   Raynaud Disease;   Vascular Disease;   Healthy Control Subjects
Intervention: Procedure: - Skin biopsy - Urine sample - Blood sample
16 Completed Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
17 Completed Raynaud's Treatment Study (RTS)
Conditions: Cardiovascular Diseases;   Heart Diseases;   Raynaud's Disease;   Vascular Diseases
Interventions: Drug: nifedipine;   Behavioral: biofeedback (psychology);   Procedure: electromyography
18 Completed Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
19 Completed PF-00489791 For The Treatment Of Raynaud's
Conditions: Raynaud's Disease;   Peripheral Vascular Disease
Intervention: Drug: PF-00489791
20 Completed St. John's Wort in the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Interventions: Drug: St. John's Wort;   Drug: Lactose

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years